MedPath

Prepidil

Prepidil Gel dinoprostone cervical gel

Approved
Approval ID

ab03de5b-782c-4f81-a8dc-7ef9969dd0cf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 11, 2019

Manufacturers
FDA

Pharmacia and Upjohn Company LLC

DUNS: 618054084

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

dinoprostone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0009-3359
Application NumberNDA019617
Product Classification
M
Marketing Category
C73594
G
Generic Name
dinoprostone
Product Specifications
Route of AdministrationVAGINAL
Effective DateDecember 11, 2019
FDA Product Classification

INGREDIENTS (3)

DINOPROSTONEActive
Quantity: 0.5 mg in 3 g
Code: K7Q1JQR04M
Classification: ACTIB
SILICON DIOXIDEInactive
Quantity: 240 mg in 3 g
Code: ETJ7Z6XBU4
Classification: IACT
TRIACETINInactive
Quantity: 2760 mg in 3 g
Code: XHX3C3X673
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Prepidil - FDA Drug Approval Details